Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-09

Clinical Trial Update: Ropivacaine Continuous Wound Infusion Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean Delivery [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ropivacaine continuous wound infusion with intrathecal morphine for postoperative analgesia after cesarean delivery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intrathecal morphine (morphine)
  • ropivacaine continuous wound infusion (ropivacaine)

Snippet

Sponsor: Saint-Joseph University | Conditions: Obstetric Pain | Phase 4 | Status: COMPLETED